Page 2 - Wesley Self News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Health News - Despite the success of vaccines for preventing COVID-19, and of drugs for treating the disease, outcomes for severely ill patients admitted to the hospital remains poor. Identifying new therapies for severe COVID-19 remains a high priority and one in which Vanderbilt University Medical Center is taking a leading role. A study published April 11 in the Journal of the American Medical Association (JAMA) evaluated two drugs that act on the renin-angiotensin system (RAS ...

Also: Vaccine recommendations for transplant recipients, new mental health degree at Belmont

A new multicenter study that includes researchers at Washington University School of Medicine, the Centers for Disease Control and Prevention (CDC), and Vanderbilt University Medical Center shows that transplant recipients who receive three doses of COVID-19 mRNA vaccine have greater protection than that provided with two doses.

New research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant (65%) than previous variants, including alpha (85%) and

New research shows that two doses of an mRNA COVID-19 vaccine result in lower effectiveness for preventing hospitalization for the omicron variant (65%) than previous variants, including alpha (85%) and delta (85%). However, importantly, a third (“booster”) vaccine dose significantly improves protection against omicron hospitalization up to 86%.The almost year-long study, led by researchers at Vanderbilt University Medical Center, the Centers for Disease Control and Prevention (CDC) ...